ArticleCancer drug resistance (Alhambra, Calif.)2019

Daunorubicin can eliminate iPS-derived cancer stem cells via ICAD/CAD-independent DNA fragmentation.

Akimasa Seno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.